TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.

Angelo Di Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.